614 related articles for article (PubMed ID: 15808757)
1. The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis.
Michowitz Y; Goldstein E; Roth A; Afek A; Abashidze A; Ben Gal Y; Keren G; George J
J Am Coll Cardiol; 2005 Apr; 45(7):1018-24. PubMed ID: 15808757
[TBL] [Abstract][Full Text] [Related]
2. Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions.
Begue B; Wajant H; Bambou JC; Dubuquoy L; Siegmund D; Beaulieu JF; Canioni D; Berrebi D; Brousse N; Desreumaux P; Schmitz J; Lentze MJ; Goulet O; Cerf-Bensussan N; Ruemmele FM
Gastroenterology; 2006 Jun; 130(7):1962-74. PubMed ID: 16762619
[TBL] [Abstract][Full Text] [Related]
3. Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: evidence for TRAIL induction via the T cell receptor signaling pathway.
Musgrave BL; Phu T; Butler JJ; Makrigiannis AP; Hoskin DW
Exp Cell Res; 1999 Oct; 252(1):96-103. PubMed ID: 10502402
[TBL] [Abstract][Full Text] [Related]
4. Role of tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus infection in mice.
Ishikawa E; Nakazawa M; Yoshinari M; Minami M
J Virol; 2005 Jun; 79(12):7658-63. PubMed ID: 15919918
[TBL] [Abstract][Full Text] [Related]
5. Cholestasis increases tumor necrosis factor-related apoptotis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity.
Higuchi H; Bronk SF; Taniai M; Canbay A; Gores GJ
J Pharmacol Exp Ther; 2002 Nov; 303(2):461-7. PubMed ID: 12388624
[TBL] [Abstract][Full Text] [Related]
6. Discordant tumor necrosis factor-alpha superfamily gene expression in bacterial peritonitis and endotoxemic shock.
Tannahill CL; Fukuzuka K; Marum T; Abouhamze Z; MacKay SL; Copeland EM; Moldawer LL
Surgery; 1999 Aug; 126(2):349-57. PubMed ID: 10455905
[TBL] [Abstract][Full Text] [Related]
7. Expression of TNF-related apoptosis-inducing ligand (TRAIL) in megakaryocytes and platelets.
Crist SA; Elzey BD; Ludwig AT; Griffith TS; Staack JB; Lentz SR; Ratliff TL
Exp Hematol; 2004 Nov; 32(11):1073-81. PubMed ID: 15539085
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells.
Secchiero P; Tiribelli M; Barbarotto E; Celeghini C; Michelutti A; Masolini P; Fanin R; Zauli G
J Cell Physiol; 2005 Nov; 205(2):246-52. PubMed ID: 15887227
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome.
Okuyama S; Komatsuda A; Wakui H; Aiba N; Fujishima N; Iwamoto K; Ohtani H; Sawada K
Nephrol Dial Transplant; 2005 Mar; 20(3):539-44. PubMed ID: 15671071
[TBL] [Abstract][Full Text] [Related]
10. Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells.
Shiraishi T; Yoshida T; Nakata S; Horinaka M; Wakada M; Mizutani Y; Miki T; Sakai T
Cancer Res; 2005 Jul; 65(14):6364-70. PubMed ID: 16024639
[TBL] [Abstract][Full Text] [Related]
11. Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice.
Secchiero P; Candido R; Corallini F; Zacchigna S; Toffoli B; Rimondi E; Fabris B; Giacca M; Zauli G
Circulation; 2006 Oct; 114(14):1522-30. PubMed ID: 17000905
[TBL] [Abstract][Full Text] [Related]
12. Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases.
Saitou Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
Hum Pathol; 2005 Oct; 36(10):1066-73. PubMed ID: 16226105
[TBL] [Abstract][Full Text] [Related]
13. Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.
Yamamoto T; Nagano H; Sakon M; Wada H; Eguchi H; Kondo M; Damdinsuren B; Ota H; Nakamura M; Wada H; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Yagita H; Monden M
Clin Cancer Res; 2004 Dec; 10(23):7884-95. PubMed ID: 15585621
[TBL] [Abstract][Full Text] [Related]
14. Expression of tumor necrosis factor alpha, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas.
Kumamoto H; Ooya K
J Oral Pathol Med; 2005 May; 34(5):287-94. PubMed ID: 15817072
[TBL] [Abstract][Full Text] [Related]
15. Expression of TNF-related apoptosis-inducing ligand in human hepatocellular carcinoma.
Shiraki K; Yamanaka T; Inoue H; Kawakita T; Enokimura N; Okano H; Sugimoto K; Murata K; Nakano T
Int J Oncol; 2005 May; 26(5):1273-81. PubMed ID: 15809718
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with active systemic lupus erythematosus.
Komatsuda A; Wakui H; Iwamoto K; Togashi M; Maki N; Masai R; Hatakeyama T; Sawada K
Clin Immunol; 2007 Oct; 125(1):26-9. PubMed ID: 17683987
[TBL] [Abstract][Full Text] [Related]
17. Effect of H. pylori on the expression of TRAIL, FasL and their receptor subtypes in human gastric epithelial cells and their role in apoptosis.
Martin JH; Potthoff A; Ledig S; Cornberg M; Jandl O; Manns MP; Kubicka S; Flemming P; Athmann C; Beil W; Wagner S
Helicobacter; 2004 Oct; 9(5):371-86. PubMed ID: 15361075
[TBL] [Abstract][Full Text] [Related]
18. Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus.
Lub-de Hooge MN; de Vries EG; de Jong S; Bijl M
Ann Rheum Dis; 2005 Jun; 64(6):854-8. PubMed ID: 15564310
[TBL] [Abstract][Full Text] [Related]
19. Identification and functional characterization of a highly polymorphic region in the human TRAIL promoter in multiple sclerosis.
Weber A; Wandinger KP; Mueller W; Aktas O; Wengert O; Grundström E; Ehrlich S; Windemuth C; Kuhlmann T; Wienker T; Brück W; Zipp F
J Neuroimmunol; 2004 Apr; 149(1-2):195-201. PubMed ID: 15020080
[TBL] [Abstract][Full Text] [Related]
20. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells.
Kayagaki N; Yamaguchi N; Nakayama M; Takeda K; Akiba H; Tsutsui H; Okamura H; Nakanishi K; Okumura K; Yagita H
J Immunol; 1999 Aug; 163(4):1906-13. PubMed ID: 10438925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]